HCTI
Healthcare Triangle, Inc.
Technology • CIK: 0001839285
Loading...
Market Cap
$24.75M
P/E (TTM)
0.0x
Rev Growth (TTM)
-21.9%
Net Margin (TTM)
-48.9%
FCF Yield (TTM)
-42.4%
FCF Margin (TTM)
-81.1%
LATEST EARNINGS
No earnings in last 90 days
Check back after next 8-K filing
Cash Flow Health
Free Cash Flow2/8 positive
TTM$-11M
Q3 '25
$-2M+17%
Q2 '25
$-3M+53%
FCF Margin
TTM-81.1%
Q3 '25-62.6%+16%
Sector: 10.0%Below Avg
OCF Margin-81.1%
OCF/NI1.66x
CapEx Coverage–
FCF Yield-42.4%
FCF Growth (2Y)–
Cash Conversion Cycle
-31 days
DSO: 49+DIO: 0−DPO: 80
Capital Allocation & Returns
Total Shareholder Yield
TTM0.0%
Div Yield0.0%
Insufficient data
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$-10.5M
Capital Return / FCF0.0%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
-130.7%
Volatile
+0.8% YoY+543.7%
P25MedianP75
25th pctl (med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
-45.2%
8Q: -38.0%
Asset Turnover
1.38x
8Q: 1.90x
Leverage (1+D/E)
–
Asset & CapEx Efficiency
Fixed Asset Turn
327.62x
8Q:448.87x
+154881.0%
Invested Cap Turn
6.22x
8Q:4.59x
-1835.6%
Depreciation Rate Trend
⚠ Declining -1876.5%
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $12.9M | $3.5M↓1.9% | $3.6M↓3.9% | $3.7M↑69.1% | $2.2M↓9.2% | $2.4M↓19.1% | $3.0M↓27.4% | $4.1M↓41.8% | $7.1M |
Operating Income | $-5.8M | $-2.6M↓90.7% | $-1.4M↑2.8% | $-1.4M↓180.7% | $-498.0K↑57.3% | $-1.2M↑15.3% | $-1.4M↑19.6% | $-1.7M↓25.3% | $-1.4M |
Net Income | $-2.5M | $1.9M↑239.3% | $-1.4M↑19.5% | $-1.7M↓26.1% | $-1.3M↓207.9% | $1.2M↑182.7% | $-1.5M↑18.9% | $-1.9M↓10.9% | $-1.7M |
Operating Cash Flow | $-10.5M | $-1.5M↑43.2% | $-2.6M↑52.6% | $-5.6M↓585.2% | $-811.0K↓213.4% | $715.0K↑176.5% | $-935.0K↓1770.0% | $-50.0K↓108.3% | $599.0K |
Free Cash Flow | $-10.5M | $-2.2M↑17.2% | $-2.6M↑52.6% | $-5.6M↓585.2% | $-811.0K↓213.4% | $715.0K↑176.5% | $-935.0K↓1770.0% | $-50.0K↓108.4% | $594.0K |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
0.0x
Volatile
8Q: -6.7x-297%
Valuation Lenses
Earnings
0.0x
vs – sector
Cash Flow
-2.2x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
–P/E per %ROIC
ROIC: -130.7%
Shareholder Returns
Dividend
–
Buyback
–
Total Yield
–
Market Cap$24.75M
EV$23.31M
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
-242/100
Below Average
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Top 10%
-1.4%
8Q:–
Return on Invested Capital (ROIC)Below Avg
-1.3%
8Q:–
+543.7%
vs Sector:0.1%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: -45.2%
Asset Turnover: 1.38x
Earnings Quality
Cash Conversion
1.66x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin8276.9%
Capital Efficiency
Invested Capital Turnover6.22x
Working Capital
Cash Conversion Cycle-31 days
Growth Quality & Momentum
Low Quality
Growth Quality Score
30/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
-21.9%
OpInc Growth YoY
-122.0%
EPS Growth YoY
N/A
FCF 3Y CAGR
N/A
Growth Quality Analysis
⚠Sustainability Index: 3.0/10 - Growth sustainability concerns
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
8276.9%
Operating
-45.2%
Top 25% in sector
Net
-48.9%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
-32.3 pts
FCF: -81.1% | Net: -48.9%
FCF margin lags net margin by 32.3 pts
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Fortress
Net Debt / EBITDA
Net Cash
(0.0x)Net Cash: $99000
Interest Coverage
–
+Net cash position: $99000
Leverage Metrics
Debt-to-Equity
–x
Balance sheet risk & solvency analysis